应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RGLS Regulus Therapeutics Inc
停牌 07-14 19:01:57 EDT
8.16
+0.00
0.00%
最高
8.16
最低
8.16
成交量
0.00
今开
8.16
昨收
8.16
日振幅
0.00%
总市值
5.65亿
流通市值
4.32亿
总股本
6,923万
成交额
7,590万
换手率
0.00%
流通股本
5,294万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Regulus Therapeutics Inc.盘中异动 股价大跌5.19%报1.28美元
市场透视 · 2025-03-04
Regulus Therapeutics Inc.盘中异动 股价大跌5.19%报1.28美元
Regulus Therapeutics Inc.盘中异动 临近收盘股价大涨5.08%报1.35美元
市场透视 · 2025-03-01
Regulus Therapeutics Inc.盘中异动 临近收盘股价大涨5.08%报1.35美元
Regulus Therapeutics Inc.盘中异动 下午盘股价大跌5.14%报1.29美元
市场透视 · 2025-02-28
Regulus Therapeutics Inc.盘中异动 下午盘股价大跌5.14%报1.29美元
Regulus Therapeutics Inc.盘中异动 急速上涨5.12%
市场透视 · 2025-02-27
Regulus Therapeutics Inc.盘中异动 急速上涨5.12%
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.51%
市场透视 · 2025-02-21
Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.51%
Regulus Therapeutics Inc.盘中异动 大幅拉升6.14%
市场透视 · 2025-02-14
Regulus Therapeutics Inc.盘中异动 大幅拉升6.14%
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.00%报1.14美元
市场透视 · 2025-02-11
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.00%报1.14美元
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.51%报1.20美元
市场透视 · 2025-02-07
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.51%报1.20美元
Regulus Therapeutics Inc.盘中异动 早盘股价大涨22.76%
市场透视 · 2025-02-04
Regulus Therapeutics Inc.盘中异动 早盘股价大涨22.76%
Regulus Therapeutics Inc.盘中异动 快速拉升5.87%
市场透视 · 2025-02-03
Regulus Therapeutics Inc.盘中异动 快速拉升5.87%
Regulus Therapeutics Inc.盘中异动 早盘快速上涨6.19%
市场透视 · 2025-01-30
Regulus Therapeutics Inc.盘中异动 早盘快速上涨6.19%
Regulus Therapeutics Inc.盘中异动 临近午盘大幅下挫5.04%
市场透视 · 2025-01-29
Regulus Therapeutics Inc.盘中异动 临近午盘大幅下挫5.04%
Regulus Therapeutics Inc.盘中异动 急速拉升5.91%
市场透视 · 2025-01-17
Regulus Therapeutics Inc.盘中异动 急速拉升5.91%
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.38%报1.23美元
市场透视 · 2025-01-14
Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.38%报1.23美元
Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.67%
市场透视 · 2025-01-13
Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.67%
Regulus Therapeutics Inc.盘中异动 早盘急速跳水5.03%
市场透视 · 2025-01-10
Regulus Therapeutics Inc.盘中异动 早盘急速跳水5.03%
Regulus Therapeutics Inc.盘中异动 股价大涨5.00%
市场透视 · 2025-01-01
Regulus Therapeutics Inc.盘中异动 股价大涨5.00%
Regulus Therapeutics Inc.盘中异动 快速下挫5.63%
市场透视 · 2024-12-28
Regulus Therapeutics Inc.盘中异动 快速下挫5.63%
Regulus Therapeutics Inc.盘中异动 早盘急速下跌5.66%报1.50美元
市场透视 · 2024-12-23
Regulus Therapeutics Inc.盘中异动 早盘急速下跌5.66%报1.50美元
Regulus Therapeutics Inc.盘中异动 股价大涨9.27%
市场透视 · 2024-12-19
Regulus Therapeutics Inc.盘中异动 股价大涨9.27%
暂无数据
公司概况
公司名称:
Regulus Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Regulus Therapeutics Inc.于2007年9月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于发现和开发针对microRNA的一流药物,以治疗具有重大医疗需求的疾病。
发行价格:
--
{"stockData":{"symbol":"RGLS","market":"US","secType":"STK","nameCN":"Regulus Therapeutics Inc","latestPrice":8.16,"timestamp":1750795200000,"preClose":8.16,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":52938400,"shares":69234089,"eps":-0.7233,"marketStatus":"停牌","change":0,"latestTime":"07-14 19:01:57 EDT","open":8.16,"high":8.16,"low":8.16,"amount":75898393.552192,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.7233,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1784073600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1349323200000,"exchange":"NASDAQ","adjPreClose":8.16,"volumeRatio":0},"requestUrl":"/m/hq/s/RGLS/tweets","defaultTab":"tweets","newsList":[{"id":"2516668804","title":"Regulus Therapeutics Inc.盘中异动 股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668804?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:48","pubTimestamp":1741031286,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时48分,Regulus Therapeutics Inc.股票出现异动,股价大幅下挫5.19%。截至发稿,该股报1.28美元/股,成交量6.9804万股,换手率0.11%,振幅5.19%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.70%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040348079637f2dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040348079637f2dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516617301","title":"Regulus Therapeutics Inc.盘中异动 临近收盘股价大涨5.08%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516617301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516617301?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:54","pubTimestamp":1740776057,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时54分,Regulus Therapeutics Inc.股票出现异动,股价急速上涨5.08%。截至发稿,该股报1.35美元/股,成交量12.0953万股,换手率0.18%,振幅5.20%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.77%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010454179896c80c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010454179896c80c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514332980","title":"Regulus Therapeutics Inc.盘中异动 下午盘股价大跌5.14%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332980?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:20","pubTimestamp":1740687621,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时20分,Regulus Therapeutics Inc.股票出现异动,股价快速下挫5.14%。截至发稿,该股报1.29美元/股,成交量11.7717万股,换手率0.18%,振幅9.37%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.39%。其相关个股中,Pepgen Inc.、Ibio, Inc.、Xortx Therapeutics Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为1923.58%、364.70%、192.31%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation,振幅分别为86.14%、67.32%、55.84%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804202198954fe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022804202198954fe4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514863962","title":"Regulus Therapeutics Inc.盘中异动 急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514863962?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:14","pubTimestamp":1740590061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时14分,Regulus Therapeutics Inc.股票出现波动,股价快速上涨5.12%。截至发稿,该股报1.34美元/股,成交量8.3862万股,换手率0.13%,振幅5.12%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.05%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270114219893c99a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270114219893c99a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513294174","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513294174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513294174?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:47","pubTimestamp":1740152856,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时47分,Regulus Therapeutics Inc.股票出现波动,股价大幅上涨5.51%。截至发稿,该股报1.34美元/股,成交量8.5957万股,换手率0.13%,振幅4.72%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234736abd7c0a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221234736abd7c0a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511711375","title":"Regulus Therapeutics Inc.盘中异动 大幅拉升6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511711375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511711375?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:37","pubTimestamp":1739475436,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时37分,Regulus Therapeutics Inc.股票出现波动,股价快速拉升6.14%。截至发稿,该股报1.21美元/股,成交量9.2638万股,换手率0.14%,振幅7.02%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.06%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140337169621f6bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140337169621f6bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380575","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380575?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:40","pubTimestamp":1739284853,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时40分,Regulus Therapeutics Inc.股票出现异动,股价急速下跌5.00%。截至发稿,该股报1.14美元/股,成交量9688股,换手率0.01%,振幅5.42%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.31%。其相关个股中,Dominari Holdings Inc.、Ocean Biomedical, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2238.82%、586.82%、229.16%,振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.,振幅分别为32.43%、31.80%、29.38%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224053961f498d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224053961f498d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744754","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.51%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744754?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:34","pubTimestamp":1738938894,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时34分,Regulus Therapeutics Inc.股票出现异动,股价急速下挫5.51%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028 Cl A涨幅较大,Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃,换手率分别为1185.99%、44.56%、34.65%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为130.43%、31.61%、20.91%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223454987dae09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223454987dae09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508745747","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨22.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508745747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508745747?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:36","pubTimestamp":1738679817,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时36分,Regulus Therapeutics Inc.股票出现异动,股价急速上涨22.76%。截至发稿,该股报1.51美元/股,成交量80.6906万股,换手率1.23%,振幅12.20%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大,Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃,换手率分别为1001.92%、714.21%、190.95%,振幅较大的相关个股有Azitra Inc、Invivyd, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为35.91%、21.70%、21.03%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223657abc22966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223657abc22966&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508144300","title":"Regulus Therapeutics Inc.盘中异动 快速拉升5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508144300?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593303,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分,Regulus Therapeutics Inc.股票出现异动,股价快速拉升5.87%。截至发稿,该股报1.06美元/股,成交量13.275万股,换手率0.20%,振幅4.87%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.36%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223503abc107d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223503abc107d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507562191","title":"Regulus Therapeutics Inc.盘中异动 早盘快速上涨6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507562191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507562191?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:35","pubTimestamp":1738247723,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时35分,Regulus Therapeutics Inc.股票出现波动,股价快速拉升6.19%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Alterity Therapeutics Limited、Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited涨幅较大,Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃,换手率分别为730.20%、129.89%、110.20%,振幅较大的相关个股有Kazia Therapeutics Limited、Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为28.25%、24.49%、21.31%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302235239876b21d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302235239876b21d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507546277","title":"Regulus Therapeutics Inc.盘中异动 临近午盘大幅下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507546277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507546277?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:59","pubTimestamp":1738083573,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时59分,Regulus Therapeutics Inc.股票出现波动,股价急速跳水5.04%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Silexion Therapeutics Corp、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为4554.51%、3431.98%、268.84%,振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp,振幅分别为236.17%、122.16%、89.64%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900593398757bc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900593398757bc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504912687","title":"Regulus Therapeutics Inc.盘中异动 急速拉升5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504912687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504912687?lang=zh_cn&edition=full","pubTime":"2025-01-17 00:27","pubTimestamp":1737044866,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日00时27分,Regulus Therapeutics Inc.股票出现异动,股价急速拉升5.91%。截至发稿,该股报1.35美元/股,成交量7.0811万股,换手率0.11%,振幅6.30%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.41%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117002746a2247aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117002746a2247aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503775570","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大跌5.38%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503775570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503775570?lang=zh_cn&edition=full","pubTime":"2025-01-14 23:36","pubTimestamp":1736869014,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日23时36分,Regulus Therapeutics Inc.股票出现波动,股价快速下挫5.38%。截至发稿,该股报1.23美元/股,成交量10.9535万股,换手率0.17%,振幅6.54%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423365498660f0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011423365498660f0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503588936","title":"Regulus Therapeutics Inc.盘中异动 早盘急速上涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503588936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503588936?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:30","pubTimestamp":1736778604,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时30分,Regulus Therapeutics Inc.股票出现波动,股价快速上涨5.67%。截至发稿,该股报1.49美元/股,成交量562股,换手率0.00%,振幅8.51%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为2331.47%、1333.25%、385.24%,振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.,振幅分别为0.00%、0.00%、0.00%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011322300496025245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011322300496025245&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RGLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502538898","title":"Regulus Therapeutics Inc.盘中异动 早盘急速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502538898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502538898?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:07","pubTimestamp":1736521634,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时07分,Regulus Therapeutics Inc.股票出现波动,股价大幅跳水5.03%。截至发稿,该股报1.42美元/股,成交量2.2065万股,换手率0.03%,振幅4.36%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.99%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230715aba60c1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230715aba60c1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500629694","title":"Regulus Therapeutics Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500629694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500629694?lang=zh_cn&edition=full","pubTime":"2025-01-01 04:46","pubTimestamp":1735677963,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日04时46分,Regulus Therapeutics Inc.股票出现异动,股价大幅拉升5.00%。截至发稿,该股报1.58美元/股,成交量18.409万股,换手率0.28%,振幅6.67%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010104460395f47862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010104460395f47862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494538023","title":"Regulus Therapeutics Inc.盘中异动 快速下挫5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494538023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494538023?lang=zh_cn&edition=full","pubTime":"2024-12-28 00:24","pubTimestamp":1735316688,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日00时24分,Regulus Therapeutics Inc.股票出现波动,股价快速下挫5.63%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Galectin Therapeutics Inc.、Abpro Holdings, Inc涨幅较大,Evaxion Biotech As、Scisparc Ltd.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为109.90%、51.83%、26.43%,振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Galectin Therapeutics Inc.、Abpro Holdings, Inc,振幅分别为147.50%、65.39%、62.45%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122800244895ef8db9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122800244895ef8db9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493576469","title":"Regulus Therapeutics Inc.盘中异动 早盘急速下跌5.66%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493576469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493576469?lang=zh_cn&edition=full","pubTime":"2024-12-23 23:32","pubTimestamp":1734967959,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日23时32分,Regulus Therapeutics Inc.股票出现异动,股价快速下挫5.66%。截至发稿,该股报1.50美元/股,成交量2.2393万股,换手率0.03%,振幅4.40%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大,Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃,换手率分别为791.08%、737.70%、653.20%,振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.,振幅分别为157.37%、104.19%、96.28%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223233239ab8e5e2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223233239ab8e5e2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492260171","title":"Regulus Therapeutics Inc.盘中异动 股价大涨9.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492260171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492260171?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:35","pubTimestamp":1734618917,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时35分,Regulus Therapeutics Inc.股票出现异动,股价大幅上涨9.27%。截至发稿,该股报1.65美元/股,成交量3197股,换手率0.00%,振幅0.00%。Regulus Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为2.38%。Regulus Therapeutics Inc.公司简介:Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922352095ea7abe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121922352095ea7abe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regulusrx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0788},{"period":"6month","weight":0.0852},{"period":"1year","weight":0.2013},{"period":"ytd","weight":0.0986}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regulus Therapeutics Inc.于2007年9月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于发现和开发针对microRNA的一流药物,以治疗具有重大医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":-0.043674},{"month":2,"riseRate":0.384615,"avgChangeRate":0.02347},{"month":3,"riseRate":0.538462,"avgChangeRate":0.105895},{"month":4,"riseRate":0.307692,"avgChangeRate":0.22053},{"month":5,"riseRate":0.538462,"avgChangeRate":0.07742},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.107927},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.130856},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.042258},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.004778},{"month":10,"riseRate":0.166667,"avgChangeRate":0.026008},{"month":11,"riseRate":0.461538,"avgChangeRate":0.057414},{"month":12,"riseRate":0.384615,"avgChangeRate":0.049982}],"exchange":"NASDAQ","name":"Regulus Therapeutics Inc","nameEN":"Regulus Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regulus Therapeutics Inc,RGLS,Regulus Therapeutics Inc股票,Regulus Therapeutics Inc股票老虎,Regulus Therapeutics Inc股票老虎国际,Regulus Therapeutics Inc行情,Regulus Therapeutics Inc股票行情,Regulus Therapeutics Inc股价,Regulus Therapeutics Inc股市,Regulus Therapeutics Inc股票价格,Regulus Therapeutics Inc股票交易,Regulus Therapeutics Inc股票购买,Regulus Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}